RYTIZER Trademark

Trademark Overview


On Tuesday, January 8, 2019, a trademark application was filed for RYTIZER with the United States Patent and Trademark Office. The USPTO has given the RYTIZER trademark a serial number of 88253353. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 7, 2022. This trademark is owned by Pfizer Inc.. The RYTIZER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
rytizer

General Information


Serial Number88253353
Word MarkRYTIZER
Filing DateTuesday, January 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, February 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, August 30, 2021ASSIGNED TO EXAMINER
Thursday, June 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 8, 2021EXTENSION 4 GRANTED
Tuesday, June 8, 2021EXTENSION 4 FILED
Tuesday, June 8, 2021TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020EXTENSION 3 GRANTED
Monday, December 14, 2020EXTENSION 3 FILED
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Saturday, May 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2020EXTENSION 2 GRANTED
Thursday, May 28, 2020EXTENSION 2 FILED
Thursday, May 28, 2020TEAS EXTENSION RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 1 GRANTED
Tuesday, December 17, 2019EXTENSION 1 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Thursday, July 25, 2019ASSIGNED TO EXAMINER
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 22, 2019ASSIGNED TO EXAMINER
Tuesday, January 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 11, 2019NEW APPLICATION ENTERED IN TRAM